- Home
- SCWO vs GNFT Comparison
SCWO vs GNFT Comparison
Compare SCWO & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCWO
- GNFT
- Stock Information
- Founded
- SCWO 2021
- GNFT 1999
- Country
- SCWO United States
- GNFT France
- Employees
- SCWO N/A
- GNFT N/A
- Industry
- SCWO Environmental Services
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SCWO Utilities
- GNFT Health Care
- Exchange
- SCWO Nasdaq
- GNFT Nasdaq
- Market Cap
- SCWO 186.8M
- GNFT 172.2M
- IPO Year
- SCWO N/A
- GNFT 2019
- Fundamental
- Price
- SCWO $0.59
- GNFT $3.60
- Analyst Decision
- SCWO
- GNFT Strong Buy
- Analyst Count
- SCWO 0
- GNFT 1
- Target Price
- SCWO N/A
- GNFT $13.00
- AVG Volume (30 Days)
- SCWO 407.6K
- GNFT 6.9K
- Earning Date
- SCWO 11-13-2024
- GNFT 09-19-2024
- Dividend Yield
- SCWO N/A
- GNFT N/A
- EPS Growth
- SCWO N/A
- GNFT N/A
- EPS
- SCWO N/A
- GNFT 0.47
- Revenue
- SCWO $313,930.00
- GNFT $86,225,222.00
- Revenue This Year
- SCWO N/A
- GNFT $145.20
- Revenue Next Year
- SCWO $5,180.00
- GNFT N/A
- P/E Ratio
- SCWO N/A
- GNFT $7.56
- Revenue Growth
- SCWO N/A
- GNFT 175.45
- 52 Week Low
- SCWO $0.54
- GNFT $3.35
- 52 Week High
- SCWO $1.99
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- SCWO 19.71
- GNFT 42.09
- Support Level
- SCWO $0.55
- GNFT $3.35
- Resistance Level
- SCWO $0.68
- GNFT $3.66
- Average True Range (ATR)
- SCWO 0.06
- GNFT 0.10
- MACD
- SCWO 0.01
- GNFT 0.03
- Stochastic Oscillator
- SCWO 11.14
- GNFT 45.45
About SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The business activities of the company include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.